| # | Drug | Count |
|---|---|---|
| 0 | ZIDOVUDINE | 79 |
| 1 | LAMIVUDINE | 75 |
| 2 | LAMIVUDINE ORAL | 74 |
| 3 | NEVIRAPINE | 33 |
| 4 | CARBOPLATIN | 4 |
| 5 | MELPHALAN | 3 |
| 6 | MELPHALAN HYDROCHLORIDE | 3 |
| 7 | TOPOTECAN | 3 |
| 8 | BEVACIZUMAB | 2 |
| 9 | CISPLATIN | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ZIDOVUDINE | 79 | 0.0076 |
| 1 | NEVIRAPINE | 33 | 0.0037 |
| 2 | LAMIVUDINE | 75 | 0.0030 |
| 3 | TOPOTECAN | 3 | 0.0005 |
| 4 | AMISULPRIDE | 1 | 0.0002 |
| 5 | RITONAVIR 100 MG | 2 | 0.0001 |
| 6 | LAMIVUDINE AND ZIDOVUDINE | 1 | 0.0001 |
| 7 | MELPHALAN HYDROCHLORIDE | 3 | 0.0001 |
| 8 | THIOTEPA | 1 | 0.0001 |
| 9 | EXTENDED PHENYTOIN SODIUM | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 76 | 0.0015 |
| 1 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 33 | 0.0014 |
| 2 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 79 | 0.0007 |
| 3 | alpha-1 Adrenergic Agonist [EPC] | 2 | 0.0005 |
| 4 | Dopamine-2 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 5 | Topoisomerase Inhibitor [EPC] | 5 | 0.0001 |
| 6 | Recombinant Human Growth Hormone [EPC] | 1 | 0.0000 |
| 7 | Protease Inhibitor [EPC] | 2 | 0.0000 |
| 8 | Cytochrome P450 3A Inhibitor [EPC] | 2 | 0.0000 |
| 9 | Platinum-based Drug [EPC] | 4 | 0.0000 |